NEW YORK, N.Y. and LONDON, U.K. — Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on meeting the challenges of measuring ROI within the changing dynamics of the pharma industry. On Wednesday 26 March 2008, Dr. Bates will deliver a presentation titled, “Are You Up to the Challenge of Measuring ROI in Changing Dynamics of the Pharma Industry?”
Bates will challenge the thinking of conference attendees and will expose where ROI goes wrong when used to guide current marketing decisions in a changing dynamic market such as pharma. She will also uncover what opportunities are available in this environment, and what can and should be measured for real results when the environment is dynamic.
Bates has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis. Under Bates’ leadership, Eularis issued three related research reports in the past year, including: Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line (www.pharmamarketingroi.com), Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things? (www.pharmaindustrysfe.com), and Ensuring Profitable Patient Adherence Programs by Effectively Using Analytics to Release the Hidden Value Available to the Bottom Line from Adherence (www.patientadherenceroi.com).
The conference will be focused on answering three pivotal areas: “Addressing the Challenges in Measuring ROI” and “Ensuring the Sales and Marketing Functions are Aligned” and “Leveraging Your Brand Potential.”
To arrange an interview with Eularis www.eularis.com, please contact Tracey Haefele at +1-646-673-8408 or via email THaefele@Eularis.com.
About Eularis
Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Eularis’ proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance.
Eularis offers pre-launch analytics, marketing mix modeling, portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions. Eularis has developed significant experience in the global pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others.
For more information about Eularis, visit www.eularis.com.
All trademarks acknowledged.
Technorati Tags: Eularis pharmaceutical analytics, Measuring Marketing ROI in Pharma Conference, Dr Andree BatesSPHERE: Related Content — CLICK HERE to See What Else is Out There!
About The Author / Editor:
Author Carly Zander has written for numerous publications including CrossMedia and Search Engine Intelligence, and in the music business for outfits like Neotrope® Records. She is a full-time content manager for the Neotrope® News Network.» Learn More About Carly Zed Zander
This material is Copr. © 2008 Advertising Industry Newswire™ and Neotrope® - Terms of Use
IMPORTANT NOTE — For questions or comments about this news story: contact the company mentioned in the above article, and NOT this Website. Advertising Industry Newswire™ cannot assist you with additional information about the company, product(s), or service(s) mentioned in the story. Information is not guaranteed to be accurate nor current.
